Ask AI
ProCE Banner Series

Ask the Experts: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages

Join this live Ask the Experts webinar with your questions about up-to-date standard of care in the detection, diagnosis, and treatment of Alzheimer’s disease, including clinical trial updates from ADPD 2026. 

Who Should Attend

This activity is intended for neurologists, geriatricians, psychiatrists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals who manage patients with AD.

All Events

Ask the Experts: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages

Upcoming Events

April

08

2026

11:00 AM - 11:30 AM Eastern Time (ET)

Virtual

Past Events

January

20

2026

7:00 PM - 8:00 PM Eastern Time (ET)

Virtual

Topics

Dementia

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge and competence to advance early detection and evidence-based care, utilizing the latest diagnostic strategies to improve patient outcomes across the care continuum of cognitive decline through Alzheimer’s disease.

Target Audience
This activity is intended for neurologists, geriatricians, psychiatrists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals who manage patients with AD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement evidence-based approaches to incorporate cognitive screening tools into routine practice for earlier identification of Alzheimer’s disease

  • Explain the underlying mechanisms of Alzheimer’s disease, including amyloid and tau pathology, neuroinflammation, and other emerging pathways

  • Evaluate the latest clinical efficacy and safety data for current and emerging treatments for AD

  • Apply current evidence supporting novel diagnostic strategies, including biomarkers, to identify early Alzheimer’s disease pathology in clinical practice

Accreditation

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191